These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1996162)

  • 1. [Current insights in the pathogenesis and treatment of duodenal ulcer].
    Beker JA; Koek GH
    Ned Tijdschr Geneeskd; 1991 Jan; 135(3):107-8. PubMed ID: 1996162
    [No Abstract]   [Full Text] [Related]  

  • 2. Peptic ulcer treatment today--is there a role for maintenance therapy?
    Breslin NP; O'Morain C
    Ital J Gastroenterol Hepatol; 1997 Apr; 29(2):116-21. PubMed ID: 9646190
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prevention of recurrence with bismuth subsalicylate in a patient with recurrent and H2 receptor antagonist refractory duodenal ulcer].
    Bayerdörffer E; Mannes GA; Pfaller P; Sauerbruch T
    Internist (Berl); 1989 Jun; 30(6):390-2. PubMed ID: 2668217
    [No Abstract]   [Full Text] [Related]  

  • 4. [Evaluation of a combination of colloidal bismuth and pirenzepine in duodenal ulcer in non-responders to anti-H2 receptors].
    Manca A; Ferraris R; Ghezzo L; Asnaghi G; Ferro GF
    Minerva Dietol Gastroenterol; 1988; 34(2):135-8. PubMed ID: 3173756
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative study of the efficacy of De-Nol and ranitidine in treating duodenal ulcer].
    Oproiu A; Pospai D; Cociaşu S; Oproiu C
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1988; 40(4):375-84. PubMed ID: 2905519
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of nizatidine, clarithromycin and bismuth subcitrate therapy for Helicobacter pylori eradication in duodenal ulcer patients--a preliminary report.
    Papp J; Juhasz L; Lakatos L; Lonovits J; Szekely I; Tarnok F; Tulassay Z; Varkonyi T
    Br J Clin Pract; 1996; 50(5):249-53. PubMed ID: 8794601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does the duodenal cell ever return to normal? A comparison between treatment with cimetidine and denol.
    Moshal MG; Gregory MA; Pillay C; Spitaels JM
    Scand J Gastroenterol Suppl; 1979; 54():48-51. PubMed ID: 295504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Cure" of Helicobacter pylori and "cure" of peptic ulcer: do they mean the same thing?
    Fennerty MB
    Am J Gastroenterol; 1995 Aug; 90(8):1203-4. PubMed ID: 7639214
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
    Park KN; Hahm JS; Kim HJ
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Present and future treatment of peptic ulcer and potential role of DE-NOL.
    Scand J Gastroenterol Suppl; 1982; 80():49-57. PubMed ID: 6761852
    [No Abstract]   [Full Text] [Related]  

  • 11. [Eradication of Helicobacter pylori infection. A new therapy standard for duodenal ulcer].
    Caspary WF; Braden B
    Internist (Berl); 1996 Dec; 37(12):1204-11. PubMed ID: 9081921
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of qid and bd administration of De-Nol in the short term treatment of duodenal ulcer.
    Lazzaroni M; Petrillo M; Bianchi Porro G
    Br J Clin Pract; 1989 Apr; 43(4):151-5. PubMed ID: 2590626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cure of Helicobacter pylori: a hidden curse?
    Srinivasan R; Minocha A
    Am J Gastroenterol; 1997 Dec; 92(12):2313-4. PubMed ID: 9399784
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cimetidine and tripotassium-dicitrato bismuthate (Duosol) in chronic duodenal ulcer].
    Bergoz R
    Schweiz Med Wochenschr; 1985 Jul; 115(29):1024-5. PubMed ID: 4048901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Characteristics of the effects of de-nol on the course of erosive-ulcerative lesions of the esophagus, stomach and duodenum associated with Helicobacter pylori].
    Grebenev AL; Miagkova LP; Golochevskaia VS; Lapina TL; Sklianskaia OA
    Klin Med (Mosk); 1995; 73(2):34-7. PubMed ID: 7609414
    [No Abstract]   [Full Text] [Related]  

  • 16. [Current perspectives in the pathogenesis and the treatment of duodenal ulcer].
    Loffeld RJ
    Ned Tijdschr Geneeskd; 1990 Nov; 134(45):2170-2. PubMed ID: 2247183
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparative evaluation of the efficacy of complex anti-ulcer therapy and monotherapy].
    Grigor'ev PIa; Khar'kovskiĭ NN; Elina NA; Iakovenko EP
    Sov Med; 1984; (2):100-1. PubMed ID: 6719194
    [No Abstract]   [Full Text] [Related]  

  • 18. A comparative study of colloidal bismuth subcitrate and cimetidine on the healing and recurrence of duodenal ulcer.
    Vantrappen G; Schuurmans P; Rutgeerts P; Janssens J
    Scand J Gastroenterol Suppl; 1982; 80():23-30. PubMed ID: 6761849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Newer drugs in the treatment of peptic ulcer.
    Tandon BN
    Trop Gastroenterol; 1985; 6(4):188-92. PubMed ID: 3913076
    [No Abstract]   [Full Text] [Related]  

  • 20. Randomized clinical trial comparing two one-week triple-therapy regimens for the eradication of Helicobacter pylori infection and duodenal ulcer healing.
    Forné M; Viver JM; Esteve M; Fernández-Bañares F; Lite J; Espinós JC; Quintana S; Salas A; Garau J
    Am J Gastroenterol; 1998 Jan; 93(1):35-8. PubMed ID: 9448170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.